 |
RF-Microchannel-Based Transdermal Delivery
Innovations in Pharmaceutical Technology, issue 27 January 2008. |
| |
|
|
TransPharma Receives European CE Mark Approval for its
Transdermal Drug Delivery Device
Drug Delivery Technology, 12.15. 2008 |
| |
|
|
TransPharma Medical Announces Licensing & Agreement
with Eli Lilly
Drug Delivery Technology, July/August 2008, Vol 8 No. 7 |
| |
|
|
Lilly agrees transdermal licensing pact with TransPharma
Drug Delivery Insight, July 4, 2008 |
|
|
|
Israel's Delivery Woman
Israel 21c, June 30, 2008 |
|
|
|
TransPharma To Get $35M Up Front In Lilly Deal
Dow Jones VentureWire, June 13, 2008 |
|
|
|
TransPharma Gets $35M
in Osteo Deal With Lilly
BioWorld
Today, June 13, 2008 |
|
|
|
Eli Lilly & Co. will pay TransPharma
Medical Ltd. $35 million to license and develop its experimental osteoporosis
drug
Bloomberg, June 12, 2008 |
|
|
|
Eli Lilly & TransPharma Medical Announce Licensing & Development Agreement
Drug Delivery Technology, June 12, 2008 |
|
|
|
Eli
Lilly buys osteoporosis drug patch for $35M
Forbes, June 12, 2008 |
|
|
|
Lilly
Gains Access to TransPharma’s Transdermal Osteoporosis Product for $35M
Genetic Engineering & Biotechnology News, June 12, 2008 |
|
|
|
Eli Lilly buys rights to TransPharma osteoporosis product
Globes, June 12, 2008 |
|
|
|
Advances in Radio-Frequency Transdermal Drug
Delivery
Pharmaceutical Technology April 2008, Volume 32, Number 4 - Supplement |
|
|
|
For Earlier News |
